title: Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder.
abstract: Peer-assessed outcomes were examined at the end of treatment (14 months after study entry) for 285 children (226 boys, 59 girls) with attention deficit hyperactivity disorder (ADHD) who were rated by their classmates (2,232 classmates total) using peer sociometric procedures. All children with ADHD were participants in the Multimodal Treatment Study of Children with ADHD (MTA). Treatment groups were compared using the orthogonal treatment contrasts that accounted for the largest amount of variance in prior MTA outcome analyses: Medication Management + Combined Treatment versus Behavior Therapy + Community Care; Medication Management versus Combined Treatment; Behavior Therapy versus Community Care. There was little evidence of superiority of any of the treatments for the peer-assessed outcomes studied, although the limited evidence that emerged favored treatments involving medication management. Post hoc analyses were used to examine whether any of the four treatment groups yielded normalized peer relationships relative to randomly selected-classmates. Results indicated that children from all groups remained significantly impaired in their peer relationships.
authors.affiliation: Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907-2081, USA. blaze@psych.purdue.edu
authors.forename: Betsy
authors.initials: B
authors.lastname: Hoza
authors.forename: Alyson C
authors.initials: AC
authors.lastname: Gerdes
authors.forename: Sylvie
authors.initials: S
authors.lastname: Mrug
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Hinshaw
authors.forename: William M
authors.initials: WM
authors.lastname: Bukowski
authors.forename: Joel A
authors.initials: JA
authors.lastname: Gold
authors.forename: L Eugene
authors.initials: LE
authors.lastname: Arnold
authors.forename: Howard B
authors.initials: HB
authors.lastname: Abikoff
authors.forename: C Keith
authors.initials: CK
authors.lastname: Conners
authors.forename: Glen R
authors.initials: GR
authors.lastname: Elliott
authors.forename: Laurence L
authors.initials: LL
authors.lastname: Greenhill
authors.forename: Lily
authors.initials: L
authors.lastname: Hechtman
authors.forename: Peter S
authors.initials: PS
authors.lastname: Jensen
authors.forename: Helena C
authors.initials: HC
authors.lastname: Kraemer
authors.forename: John S
authors.initials: JS
authors.lastname: March
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Newcorn
authors.forename: Joanne B
authors.initials: JB
authors.lastname: Severe
authors.forename: James M
authors.initials: JM
authors.lastname: Swanson
authors.forename: Benedetto
authors.initials: B
authors.lastname: Vitiello
authors.forename: Karen C
authors.initials: KC
authors.lastname: Wells
authors.forename: Timothy
authors.initials: T
authors.lastname: Wigal
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000523:psychology* / Q000628:therapy*; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D023381:Endpoint Determination; D005260:Female; D006801:Humans; D008297:Male; D010379:Peer Group; D012919:Social Behavior; D016896:Treatment Outcome
chemical_list: D000697:Central Nervous System Stimulants